Research Article
Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric Rhabdomyosarcoma
Table 3
Mean age of first tumor onset according to MDM2 SNP309 or p53 codon 72 genotype.
| | Allele (frequency) | Genotype | Number of patients (%) | Mean age ± STDEV (years) |
| MDM2 SNP309 | T (60%) | T/T | 16 (40) | 6.4 ± 5.2 | | T/G | 16 (40) | 6.7 ± 5.4 | G (40%) | G/G | 8 (20) | 7.6 ± 3.7 | | T/G + G/G | 24 (60) | 7.0 ± 4.8 |
| P53 codon 72 SNP | Arg (75%) | Arg/Arg | 24 (60) | 6.3 ± 5.2 | | Arg/Pro | 12 (30) | 7.5 ± 4.8 | Pro (25%) | Pro/Pro | 4 (10) | 7.0 ± 4.8 | | Arg/Arg + Arg/Pro | 36 (90) | 6.7 ± 5.0 |
|
|